Northeast Pharmaceutical Group Co., Ltd. (000597)
Northeast Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Northeast Pharmaceutical", stock code: 000597) is a listed company of Liaoning Fangda Group Industrial Co., Ltd. (hereinafter referred to as "Fangda group"). The company, formerly known as northeast general pharmaceutical factory, was founded in 1946. It has helped to build 52 pharmaceutical enterprises in 19 provinces and cities in China, and transported more than 1300 cadres. It is known as the cradle of China's national pharmaceutical industry.
At present, Northeast Pharmaceutical has chemical raw materials, chemical preparations, pharmaceutical business, pharmaceutical engineering, biomedicine and other major business sectors, covering the whole industry chain of pharmaceutical R & D, manufacturing and distribution, with more than 8500 employees and a total asset of 12 billion yuan. The company mainly produces vitamin series drugs, anti infective drugs, gynecological and obstetric drugs, digestive system drugs, urinary system drugs, antiviral drugs, cardiovascular and cerebrovascular drugs, analgesic and antitussive drugs, biological diagnosis drugs, big health field drugs, more than 400 kinds of chemical raw materials, pharmaceutical intermediates and preparation products, Leading products are exported to more than 100 countries and regions.
The company has a strong product manufacturing system. The preparation production base covers an area of 180000 square meters, with more than 30 production lines and an annual production capacity of 10 billion tablets (tablets, pills, granules, bottles). The API production base covers an area of 910000 square meters. It is a national demonstration factory for the intelligent manufacturing of bulk API and pharmaceutical intermediates. Its main products include vitamin C and its series, L-carnitine series, fosfomycin series, piracetam, carboprost methyl ester, amantadine, sucralfate, berberine, chloramphenicol, etc. it is fully oriented to the downstream Northeast Pharmaceutical industry chain extension, Form a comprehensive competitive advantage that is difficult to copy.
The company is a state-level green factory, with the most advanced environmental protection treatment system in the country, realizing the comprehensive treatment of sewage, exhaust gas, noise and solid waste. The treatment capacity of API wastewater treatment system reaches 50000 m3 / D, leading the whole industry in technical level. The incinerator can handle 9000 tons of hazardous waste in the whole year, and the exhaust emission reaches the EU standard. The circular economy industrial park realizes the resource treatment of production waste and turns waste into treasure.
Northeast Pharmaceutical has a sound quality management system, product quality in line with the latest GMP, EP, USP, JP, BP, CP and other quality standards. Many products have passed EDQM, FDA, Japanese Ministry of health and welfare, BRC, halal, kosher and other international high-end certification. The leading products have passed the registration and quality audit in the United States, Europe, Japan, Brazil, Russia, Poland and other countries and regions.
Northeast Pharmaceutical is not only an important pharmaceutical production and export base in China, but also has independent business companies such as pharmaceutical research institute, engineering design company, equipment manufacturing and installation company, international trade company, measurement and testing company, hazardous chemicals transportation company, among which five are high-tech enterprises.
Northeast Pharmaceutical business network covers all prefecture level cities and counties in Liaoning, and extends to the three provinces in Northeast China. Northeast pharmacy has more than 100 chain stores. Pharmaceutical e-commerce business realizes online and offline integration, and business model innovation continues to advance.
The company has two well-known trademarks of "northeast" and "fumeixin" in China, as well as a large number of famous trademarks of provinces and cities, ranking 28th in the list of "top 100 comprehensive strength of industrial enterprises in China's chemical pharmaceutical industry in 2018".
Facing the future development, Northeast Pharmaceutical will adhere to the enterprise values of "operating enterprises must be beneficial to the government, enterprises and employees", and strive to build Northeast Pharmaceutical into a large-scale comprehensive medical and health industry group with international reputation and domestic leading.
>> tungsten carbide rings silver